Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,675,000 | 2,016,000 | 1,734,000 | 2,022,000 | 1,724,000 |
| Receivables | 1,675,000 | 1,631,000 | 1,531,000 | 1,598,000 | 1,457,000 |
| Inventories | 1,430,000 | 1,407,000 | 1,351,000 | 1,472,000 | 1,516,000 |
| Other current assets | 776,000 | 855,000 | 1,884,000 | 894,000 | 925,000 |
| TOTAL | $6,758,000 | $6,101,000 | $6,694,000 | $6,160,000 | $5,803,000 |
| Non-Current Assets | |||||
| PPE Net | 2,082,000 | 2,053,000 | 2,084,000 | 2,064,000 | 2,079,000 |
| Intangibles | 16,662,000 | 16,859,000 | 15,868,000 | 16,934,000 | 17,261,000 |
| Other Non-Current Assets | 5,665,000 | 5,887,000 | 6,131,000 | 5,688,000 | 5,682,000 |
| TOTAL | $24,409,000 | $24,799,000 | $24,083,000 | $24,686,000 | $25,022,000 |
| Total Assets | $31,168,000 | $30,900,000 | $30,777,000 | $30,845,000 | $30,823,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 262,000 | 13,000 | 13,000 | 11,000 | 254,000 |
| Accounts payable and accrued liabilities | 689,000 | 615,000 | 513,000 | 452,000 | 408,000 |
| Accrued Expenses | 2,442,000 | 2,060,000 | 2,197,000 | 2,195,000 | 1,718,000 |
| Other current liabilities | 680,000 | 705,000 | 958,000 | 644,000 | 729,000 |
| TOTAL | $4,073,000 | $3,393,000 | $3,681,000 | $3,302,000 | $3,108,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,847,000 | 9,082,000 | 9,130,000 | 9,325,000 | 9,278,000 |
| Other Non-Current Liabilities | 2,190,000 | 2,370,000 | 2,309,000 | 2,132,000 | 2,236,000 |
| TOTAL | $11,152,000 | $11,788,000 | $11,769,000 | $11,979,000 | $12,099,000 |
| Total Liabilities | $15,226,000 | $15,181,000 | $15,451,000 | $15,281,000 | $15,207,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,423,853 | 1,420,911 | 1,417,166 | 1,431,921 | 1,430,675 |
| Common Shares | 17,000 | 17,000 | 17,000 | 17,000 | 17,000 |
| Retained earnings | -1,878,000 | -2,050,000 | -2,378,000 | -2,574,000 | -2,405,000 |
| Other shareholders' equity | 237,000 | 253,000 | 206,000 | 151,000 | 131,000 |
| TOTAL | $15,942,000 | $15,719,000 | $15,326,000 | $15,564,000 | $15,616,000 |
| Total Liabilities And Equity | $31,168,000 | $30,900,000 | $30,777,000 | $30,845,000 | $30,823,000 |